XL, D., LM, S., BC, T., JL, B., & BR, D. (2021). Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker. PloS one, 16(11), e0260107. https://doi.org/10.1371/journal.pone.0260107
Chicago Style (17th ed.) CitationXL, Du, Simpson LM, Tandy BC, Bettencourt JL, and Davis BR. "Risk of Hospitalized and Non-hospitalized Gastrointestinal Bleeding in ALLHAT Trial Participants Receiving Diuretic, ACE-inhibitor, or Calcium-channel Blocker." PloS One 16, no. 11 (2021): e0260107. https://doi.org/10.1371/journal.pone.0260107.
MLA (9th ed.) CitationXL, Du, et al. "Risk of Hospitalized and Non-hospitalized Gastrointestinal Bleeding in ALLHAT Trial Participants Receiving Diuretic, ACE-inhibitor, or Calcium-channel Blocker." PloS One, vol. 16, no. 11, 2021, p. e0260107, https://doi.org/10.1371/journal.pone.0260107.